Commercial & Medical Affairs - software & AI news

Daily news on software, AI, and companies shaping commercial & medical affairs.

Showing 52 results
A vial of drug compound on a lab bench with a clinical device in the background.

Jun 15, 2026

The future of life sciences communication starts with Prezent

The life sciences sector is poised for significant growth, projected to reach nearly $278 billion by 2034, largely driven by advancements in AI and strategic acquisitions. However, mere scientific innovation is insufficient for commercial success in this highly regulated field. Effective communication of complex clinical data and real-world evidence is essential to maintain momentum for promising clinical developments.Prezent has emerged as a pivotal player in addressing this communication chall
A training manual and coffee cup in a dimly lit office during blue hour.

Jun 12, 2026

Skillet Launches AI Commercial Excellence Platform for Pharmaceutical & Medtech Teams

Skillet has unveiled an AI-driven commercial excellence platform designed specifically for the life sciences sector, marking its entrance from stealth mode. This innovative platform aims to enhance the training and preparation of sales teams in pharmaceuticals and medical devices.Developed by Wayground, Skillet offers a suite of AI tools that includes roleplay simulations, coaching for managers, and call preparation features tailored to the unique challenges faced by sales representatives. Early
A pill bottle on an office desk with a data chart in the background.

Jun 9, 2026

From Dashboards to Decisions: How AI Is Reshaping Pharma Brand Strategy

The integration of AI into pharmaceutical brand strategy is transforming decision-making processes, enabling faster and more effective responses to market dynamics.In the rapidly evolving life sciences sector, pharmaceutical brand leaders face unprecedented challenges due to heightened competition and shifting economic policies. As organizations increasingly rely on data analytics, the focus has shifted from merely collecting data to utilizing AI-driven insights for swift decision-making. This t
A clipboard with a checkmark in a dark monochromatic style.

Jun 9, 2026

Quantified Launches New AI Sales Coaching Platform to Transform How Life Sciences Teams Prepare, Coach, and Win

Quantified has launched an innovative AI Sales Coaching Platform aimed at enhancing the readiness and performance of life sciences commercial teams. This platform expands upon its existing AI Roleplay solution, integrating Adaptive AI and various coaching capabilities to support representatives throughout their entire lifecycle.The newly introduced platform is designed to improve critical metrics such as rep readiness, message adherence, and field execution. It utilizes Adaptive AI to tailor coa
Minimalist illustration of a pill bottle and healthcare professional in dark colors with lime accents.

Jun 8, 2026

How AI is rewriting customer engagement in pharma

The integration of AI in customer engagement within the pharmaceutical industry is reshaping how companies interact with healthcare professionals and patients. Despite the potential benefits, many commercial leaders express frustration over the lack of tangible results from AI initiatives, emphasizing the need for meaningful conversations in an increasingly complex healthcare landscape.Executives are grappling with the challenge of enhancing patient outcomes amid a complicated and constrained sy
A pill bottle and prescription pad on a pharmacy counter in low light.

Jun 4, 2026

Veeva Rides AI Wave As Pharma Cloud Story Accelerates

Veeva Systems Inc. is experiencing significant growth, driven by robust financial results and advancements in AI technology. In its recent quarterly report, Veeva announced a 16% year-on-year revenue increase, reaching $882.9 million, and a 13% rise in adjusted operating income to $395.4 million. These figures surpassed analyst expectations, prompting the company to raise its fiscal 2027 guidance across all major metrics. Analysts from BTIG and Needham have affirmed their Buy ratings, highlighti
Minimalist illustration of a pill and data flow diagram in dark colors.

Jun 2, 2026

Connect Commercial Models to Improve Decision-Making in the Pharma AI Era, Upcoming Webinar Hosted by Xtalks

The upcoming webinar titled "Connect Commercial Models to Improve Decision-Making in the Pharma AI Era" will delve into how AI can enhance decision-making within pharmaceutical organizations.The event will focus on the transition from fragmented engagement strategies to more integrated commercial models, emphasizing the importance of governance and trust in AI-driven workflows. Attendees will explore how aligning medical, marketing, and sales functions through shared insights can lead to more ef
A vial of medication on a lab bench

Jun 2, 2026

Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma

Salesforce has recently reported that over 140 life sciences organizations, including major players like Novartis and AstraZeneca, are utilizing its Agentforce Life Sciences platform. This announcement came during the Veeva Commercial Summit, where Salesforce emphasized its AI-driven approach across various engagement areas in the life sciences sector.Joe Ferraro, Salesforce's SVP and GM of life sciences, highlighted that their platform supports a wide array of functions, from patient and clinic
A pill bottle on a desk in a dimly lit office

May 28, 2026

Solstice Secures $21M for AI-Native Pharmaceutical Marketing Platform

Solstice, an AI-driven pharmaceutical marketing platform, has raised $21 million in Series A funding led by Transformation Capital, increasing its total funding to about $25 million. This investment aims to enhance its technical infrastructure and expedite its market entry strategies.The company addresses significant delays in pharmaceutical marketing, where the review process for marketing materials can take up to three months due to stringent medical, legal, and regulatory (MLR) checks. By int
A minimalist illustration of a pill on a solid background.

May 28, 2026

Solstice: $21 Million Series A Raised To Accelerate Pharma Commercialization

Solstice, an AI-driven marketing agency, has successfully raised $21 million in Series A funding, aimed at enhancing the commercialization processes for pharmaceuticals. This funding round, led by Transformation Capital, brings the company's total funding to around $25 million.This new investment will facilitate Solstice's expansion into the market, drive product development, and enhance team capabilities in both product and customer-facing roles. The agency is dedicated to streamlining the comm
A printed healthcare provider directory on a wooden desk in a modern office.

May 28, 2026

H1 Receives $40M Investment in Round Led by CVS Health Ventures

H1, a company focused on enhancing healthcare operations through AI, has secured a significant $40 million investment led by CVS Health Ventures. This funding aims to bolster their ongoing initiatives to improve healthcare provider connections and streamline patient access to care.The investment from CVS Health Ventures, which is dedicated to fostering healthcare innovation, follows a series of successful collaborations between the two entities. Notably, they have developed an AI model that sign
A pill bottle on a desk with marketing materials in a dimly lit office.

May 28, 2026

AI-native pharma marketing startup Solstice raises $21M to cut drug campaign timelines from 3 months to 10 days

AI-driven startup Solstice has successfully raised $21 million in Series A funding to revolutionize pharmaceutical marketing timelines, reducing the approval process from months to mere days.Based in New York, Solstice aims to streamline the traditionally cumbersome marketing and regulatory review processes in the pharmaceutical industry. With over a dozen pharmaceutical partners, including major global brands, the startup leverages AI to cut the time from content creation to regulatory submissi